Antibody Drug Development Summit - Autumn 2021 | The Jackson Laboratory

Antibody Drug Development Summit - Autumn 2021

View the Autumn 2021 Antibody Drug Development Summit on-demand.

about 2 years ago
The Humanized FcRn Platform: An Essential Tool for Preclinical PK Assessment of Therapeutic Antibody Candidates

Greg Christianson, Study Director, In Vivo Services, The Jackson Laboratory speaks about the use of human FcRn transgenic mouse models to select antibody therapeutic candidates with optimum pharmacoki

Watch Video
about 2 years ago
Human Immune System Engrafted Mice and Their Role in Human Antibody-Based Drug Development

Brian Soper, Ph.D., Senior Manager, Technical Information Services, The Jackson Laboratory speaks about human immune system engrafted mice and their role in human antibody-based drug development.

Watch Video
about 2 years ago
Testing the Efficacy of Immuno-Modulatory Antibodies in Humanized Mice

Aaron Rose, Ph.D., Senior Study Director, In Vivo Services, The Jackson Laboratory speaks about testing the efficacy of immunomodulatory antibodies in humanized mice.

Watch Video
about 2 years ago
A Humanized Preclinical in Vivo System to Predict the Immunotoxicity of Antibody Drug Candidates

James Keck, Ph.D., Senior Director, Innovation and Product Development, at JAX speaks about a humanized preclinical in vivo system to predict the the immunotoxicity of antibody drug candidates.

Watch Video